An administrative court run by the U.S. Patent and Trademark Office has rejected arguments by Moderna that an ABUS Stock patent known...
Things are about to get very exciting for investors in Moderna Inc (NASDAQ:MRNA). A clinical trial evaluating a vaccine designed to protect against...